Position in GMAB
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,346,441
-$167,790 QoQ
Shares Held
49,015
-13.2% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#84
of 292 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in GMAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,163,799,259 across 230 Biotechnology names. GMAB ranks #146 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in GMAB
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,346,441 | 49,015 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,514,231 | 56,438 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,713,188 | 55,623 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,727,641 | 56,330 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,097,149 | 53,105 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $995,075 | 50,821 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $951,985 | 45,615 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,719,009 | 70,509 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $2,137,356 | 85,052 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,805,916 | 93,812 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $2,978,823 | 93,556 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $3,343,031 | 94,784 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $3,563,855 | 93,761 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,799,677 | 74,144 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,560,387 | 60,415 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,762,716 | 54,862 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,725,154 | 53,098 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $660,031 | 18,243 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $611,241 | 15,451 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $259,665 | 5,942 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $215,664 | 5,282 | Shares | Sole | 2021-08-12 | |
| 2020-12-31 | $214,766 | 5,282 | Shares | Sole | 2021-03-08 | |
| No filing history on record for this holder in this stock. | ||||||